Life Sciences Tools & Services (8) | Development Agreements (8)

Browse by Company

Adaptive Biotechnologies Corp (1)
Bio-Techne (1)
CODEXIS INC (1)
NEOGENOMICS INC (1)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (2)
PPD, Inc. (1)
Seer, Inc. (1)

Recent Contracts

Amendment to Development and Commercialization Agreement, dated as of June 3, 2021, by and between Pacific Biosciences of California, Inc. and Invitae Corporation (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on August 6, 2021)
Assignment and Assumption Agreement, dated as of May 11, 2017, by and among Jaguar Holding Company I, Eagle Holding Company I, Pharmaceutical Product Development, LLC, and David... (PPD, Inc., Filed With SEC on February 26, 2021)
Development and Commercialization Agreement by and between the Registrant and Invitae Corporation dated January 12, 2021 (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on February 26, 2021)
Umbrella Development & Supply Agreement between the Registrant and Hamilton Company, dated March 9, 2020 (Seer, Inc., Filed With SEC on November 12, 2020)
Development, Supply and Commercialization Agreement by and between Bio-Techne Corporation and Kantaro Biosciences, LLC dated May 18, 2020 (portions of which have been redacted as... (Bio-Techne, Filed With SEC on May 19, 2020)
Letter Agreement, effective as of February 21, 2020, by and between Codexis, Inc. and GlaxoSmithKline Intellectual Property Development Limited (CODEXIS INC, Filed With SEC on May 8, 2020)
Development Agreement, dated September 13, 2019, by and between NeoGenomics Laboratories, Inc. and Seagate Alico I, LLC (NEOGENOMICS INC, Filed With SEC on November 13, 2019)
IVD Test Kit Development and Supply Agreement between Illumina, Inc. and Adaptive Biotechnologies Corporation, effective September 23, 2019 (Adaptive Biotechnologies Corp, Filed With SEC on November 12, 2019)